找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Intensity-Modulated Radiation Therapy; Clinical Evidence an Yasumasa Nishimura,Ritsuko Komaki Book 2015 Springer Japan 2015 high-dose radia

[复制链接]
楼主: Coarse
发表于 2025-3-30 08:20:25 | 显示全部楼层
Oropharyngeal Cancerd has been associated with HPV infection. The prognosis of patients with HPV-related oropharyngeal cancer is known to be good; therefore, radiotherapy is the preferred treatment due to its functional and cosmetic advantages. Oropharyngeal cancer is considered a good candidate for IMRT because of the
发表于 2025-3-30 14:53:50 | 显示全部楼层
Postoperative Intensity-Modulated Radiation Therapy for Head and Neck Cancers: A Case-Based Reviewty-modulated radiation therapy (IMRT) is preferred over previous techniques primarily due to (1) the ability to conform the high-dose regions around geometrically complex targets, (2) the ability to build steep dose gradients between targets and nearby critical structures, and (3) the ability to gen
发表于 2025-3-30 20:26:07 | 显示全部楼层
发表于 2025-3-31 00:32:53 | 显示全部楼层
发表于 2025-3-31 02:01:41 | 显示全部楼层
Mesothelioma mesothelioma). The standard of care for localized mesothelioma involves multimodality therapy. Whether the surgery should be extrapleural pneumonectomy or a lung-sparing approach such as pleurectomy/decortication has not been established, as the former has been linked with higher morbidity with no
发表于 2025-3-31 07:21:48 | 显示全部楼层
发表于 2025-3-31 11:11:52 | 显示全部楼层
发表于 2025-3-31 16:50:15 | 显示全部楼层
Thoracic Esophageal Cancercoupled with esophagectomy. Several randomized trials have demonstrated that the trimodality approach (chemotherapy, radiation, and surgery) provides the best survival outcomes for patients with thoracic esophageal cancer. However, given the proximity of the heart and lungs to the treatment fields,
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-23 09:47
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表